Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference
International Journal of Clinical Oncology · 2025
DOI: 10.1007/s10147-025-02871-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Makoto Hiraoka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Cancer Survivors, Insurance, Health, Neoplasms, Neoplasms, Second Primary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asahi Mutual Life Insurance Company, The University of Tokyo.
Abstract (Originalsprache)
Background
Limited data are available on relative survival (RS) among cancer survivors enrolled in private cancer insurance in Japan. Additionally, the incidence of second primary cancers or recurrences, as applicable, after a certain period remains unclear.
Methods
We analyzed 8,846 cancer survivors, including carcinoma in situ, aged 15–79 years, enrolled in private cancer insurance between April 2005 and September 2021, and diagnosed before April 2022. Using the entire insurance-enrolled population as the reference, we estimated sex- and age group-specific RS, conditional RS (CRS), and age-standardized RS (ASR) by cancer type. The cumulative incidence of second primary cancers or recurrences, as applicable, was calculated among cancer-free 3-, 4-, and 5-year survivors.
Results
Median ages at first diagnosis were 61.5 years for males and 55.0 years for females. Over median follow-up of 3.40 years, 1,772 deaths (45.4 per 1,000 person-years) occurred. The 5-year RS declined with age: 81.8% for males and 94.8% for females aged 15–39, but 68.5% and 71.8% for those aged 70–79. The 5-year CRS increased with time since diagnosis, exceeding 90% among 5-year survivors in all groups except males aged 70–79. Liver cancer survivors had the highest incidence of second primary cancers or recurrences, predominantly due to recurrences, even after 5 cancer-free years.
Conclusion
We estimated sex- and age group-specific RS, CRS, and ASR by cancer type, and the incidence of second primary cancers or recurrences, using a database of private cancer insurance policyholders, though the findings may not be generalizable to the national population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
- Asahi Mutual Life Insurance Company, Tokyo, Japan.
- Medical Information System Development Center, Tokyo, Japan.
- Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Förderung
- Asahi Mutual Life Insurance Company
- The University of Tokyo
Zitieren
APA
Hiraoka, M., Uekusa, H., Okada, A., Inoue, R., Ikeda-Kurakawa, K., Otsuka, Y., Namiki, D., Yamamoto, R., Yamauchi, T., Nangaku, M., Ohe, K., Yamaguchi, S., & Kadowaki, T. (2025). Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02871-6
Vancouver
Hiraoka M, Uekusa H, Okada A, Inoue R, Ikeda-Kurakawa K, Otsuka Y, et al. Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02871-6
BibTeX
@article{Hiraoka2025,
author = {Hiraoka, Makoto and Uekusa, Hayaka and Okada, Akira and Inoue, Reiko and Ikeda-Kurakawa, Kayo and Otsuka, Yusuke and Namiki, Daisuke and Yamamoto, Ryuichi and Yamauchi, Toshimasa and Nangaku, Masaomi and Ohe, Kazuhiko and Yamaguchi, Satoko and Kadowaki, Takashi},
title = {Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference},
journal = {International Journal of Clinical Oncology},
year = {2025},
doi = {10.1007/s10147-025-02871-6}
}
EUVIMED